Hyperion DeFi Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Hyperion DeFi Inc.
Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.
Frequently asked questions
To buy Hyperion DeFi Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Hyperion DeFi Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Hyperion DeFi Inc. is HYPD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Hyperion DeFi Inc. has its primary listing on NASDAQ. You can trade Hyperion DeFi Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Hyperion DeFi Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Hyperion DeFi Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Hyperion DeFi Inc..